Our Products
General Introduction
Ummon HealthTech is revolutionizing decision-making in oncology.
Using AI and Deep Learning, our solutions accurately predict which treatments will work for each patient, ensuring a truly personalized approach. By optimizing available resources and maximizing the effectiveness of therapeutic decisions, we offer doctors powerful tools to improve clinical outcomes. Discover our innovations that redefine medicine and put performance at the service of patients.
Screening assistance
Cervical cancer screening is done through a smear test that searches for the presence of abnormal cells in the cervix. Our product, the p16/ki67 AutoReader, helps identify suspicious cells that may be difficult to detect, reducing potential medical errors and drastically speeding up the diagnostic process.
Virtual Molecular Biology
Molecular biology tests like DNA sequencing are critical for accessing innovative therapies, such as targeted treatments for cancer. Chara-prAIdict predict the risk of gene mutation from a scanned image of a diagnostic biopsy, helping oncologists choose the right treatment.
Residual Disease Prediction
Predicting the effectiveness of chemotherapy treatments is an essential challenge in oncology. Chemo-prAIdict helps predict tumor chemosensitivity, allowing physicians to decide on the best available treatment for each patient.
Learn more:p16/ki67 AutoReaderp16/ki67 AutoReader
Revolutionizing Cervical Cancer Screening with Automated Cytology
Learn more:CrawlerCrawler
A distributed and targeted recruitment solution for precision medicine in oncology.
Learn more:Chemo-pr<span style='color:var(--chemo-color)'>AI</span>dictChemo-prAIdict
Predicting tumor chemosensitivity & relapse risk using Deep Learning.